These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28491355)

  • 1. Otogenic meningoencephalomyelitis due to
    Siak MK; Paul A; Drees R; Arthur I; Burrows AK; Tebb AJ; Malik R
    JFMS Open Rep; 2015; 1(1):2055116915585022. PubMed ID: 28491355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recrudescent cryptococcosis, caused by Cryptococcus gattii (molecular type VGII), over a 13-year period in a Birman cat.
    Kluger EK; Karaoglu HK; Krockenberger MB; Della Torre PK; Meyer W; Malik R
    Med Mycol; 2006 Sep; 44(6):561-6. PubMed ID: 16966175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jet-Setting Koalas Spread Cryptococcus gattii VGII in Australia.
    Schmertmann LJ; Danesi P; Monroy-Nieto J; Bowers J; Engelthaler DM; Malik R; Meyer W; Krockenberger MB
    mSphere; 2019 Jun; 4(3):. PubMed ID: 31167945
    [No Abstract]   [Full Text] [Related]  

  • 4. Bilateral cholesterol granulomas in the middle ear cavities of a cat with sinonasal disease successfully removed via video-otoscopy.
    Doulidis PG; Klang A; Gumpenberger M; Panakova L
    J Am Vet Med Assoc; 2022 Mar; 260(10):1-4. PubMed ID: 35263296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine.
    Espinel-Ingroff A; Chowdhary A; Cuenca-Estrella M; Fothergill A; Fuller J; Hagen F; Govender N; Guarro J; Johnson E; Lass-Flörl C; Lockhart SR; Martins MA; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Pfaller MA; Schell WA; Trilles L; Kidd S; Turnidge J
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3107-13. PubMed ID: 22391546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility to antifungal agents and genotypes of Brazilian clinical and environmental Cryptococcus gattii strains.
    Silva DC; Martins MA; Szeszs MW; Bonfietti LX; Matos D; Melhem MS
    Diagn Microbiol Infect Dis; 2012 Apr; 72(4):332-9. PubMed ID: 22341512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
    Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
    Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Aller AI; Canton E; Castañón-Olivares LR; Chowdhary A; Cordoba S; Cuenca-Estrella M; Fothergill A; Fuller J; Govender N; Hagen F; Illnait-Zaragozi MT; Johnson E; Kidd S; Lass-Flörl C; Lockhart SR; Martins MA; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Pfaller MA; Schell WA; St-Germain G; Trilles L; Turnidge J
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5898-906. PubMed ID: 22948877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility testing of amphotericin B for Cryptococcus neoformans variety grubii AFLP1/VNI and Cryptococcus gattii AFLP6/VGII by CLSI and flow cytometry.
    Morales BP; Trilles L; Bertho ÁL; Junior IN; de Oliveira Rde V; Wanke B; Lazéra Mdos S
    Mycoses; 2015 May; 58(5):273-9. PubMed ID: 25756839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptococcosis due to
    Brito-Santos F; Reis RS; Coelho RA; Almeida-Paes R; Pereira SA; Trilles L; Meyer W; Wanke B; Lazéra MDS; Gremião IDF
    Med Mycol Case Rep; 2019 Jun; 24():61-64. PubMed ID: 31061785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and microbiological characteristics of Cryptococcus gattii isolated from 7 hospitals in China.
    Jin L; Cao JR; Xue XY; Wu H; Wang LF; Guo L; Shen DX
    BMC Microbiol; 2020 Mar; 20(1):73. PubMed ID: 32228457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Middle ear cholesteatoma in two cats diagnosed with the aid of video-otoscopy.
    Botelho CB; Tortoriello R; Koch SN; Lopes NL; Lucas R; Fernandes JI
    JFMS Open Rep; 2023; 9(2):20551169231196528. PubMed ID: 37781725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological, Clinical and Outcome Aspects of Patients with Cryptococcosis Caused by Cryptococcus gattii from a Non-endemic Area of Brazil.
    Damasceno-Escoura AH; de Souza ML; de Oliveira Nunes F; Pardi TC; Gazotto FC; Florentino DH; Mora DJ; Silva-Vergara ML
    Mycopathologia; 2019 Feb; 184(1):65-71. PubMed ID: 30415450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptococcus gattii infections.
    Chen SC; Meyer W; Sorrell TC
    Clin Microbiol Rev; 2014 Oct; 27(4):980-1024. PubMed ID: 25278580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility.
    Lee GA; Arthur I; Merritt A; Leung M
    Med Mycol; 2019 Nov; 57(8):1004-1010. PubMed ID: 30649538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic and Phenotypic Diversity of
    Barcellos VA; Martins LMS; Fontes ACL; Reuwsaat JCV; Squizani ED; de Sousa Araújo GR; Frases S; Staats CC; Schrank A; Kmetzsch L; Vainstein MH
    Front Microbiol; 2018; 9():132. PubMed ID: 29467743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII.
    Aminnejad M; Diaz M; Arabatzis M; Castañeda E; Lazera M; Velegraki A; Marriott D; Sorrell TC; Meyer W
    Mycopathologia; 2012 Jun; 173(5-6):337-46. PubMed ID: 22081254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal Cryptococcus gattii genotype AFLP6/VGII infection in a HIV-negative patient: case report and a literature review.
    Favalessa OC; Lázera Mdos S; Wanke B; Trilles L; Takahara DT; Tadano T; Dias LB; Vieira AC; Novack GV; Hahn RC
    Mycoses; 2014 Oct; 57(10):639-43. PubMed ID: 24980291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcus gattii molecular type VGII infection associated with lung disease in a goat.
    da Silva EC; Guerra JM; Torres LN; Lacerda AM; Gomes RG; Rodrigues DM; Réssio RA; Melville PA; Martin CC; Benesi FJ; de Sá LR; Cogliati B
    BMC Vet Res; 2017 Feb; 13(1):41. PubMed ID: 28173801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated Cryptococcus deuterogattii (AFLP6/VGII) infection in an Arabian horse from Dubai, United Arab Emirates.
    Kinne J; Joseph M; Wernery U; Nogradi N; Hagen F
    Rev Iberoam Micol; 2017; 34(4):229-232. PubMed ID: 28595777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.